Ranked by rounds participated in, from announcements in Sep 25, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
New companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Star Therapeutics $200M Private financingOMass Therapeutics $310M Series CSoufflé Therapeutics $135M Series BNew companies 3 · Follow-on 0
Stages: Seed 2, Series A 1
Estuary Biotherapeutics $93M Series AUndecimal Bio $18M SeedAptadir Therapeutics €40M SeedNew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Series C+ 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 3 · Follow-on 0
Stages: Seed 2, Series A 1
Molagri Undisclosed SeedSensible Biotechnologies $47M Series AWonderTx $125K SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Warhound $200M SeedSoufflé Therapeutics $135M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Warp Sciences $215M Series AWarhound $200M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Nouscom €120M Series DAptadir Therapeutics €40M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Nouscom €120M Series DEdonia €15M Series A financing package including non-dilutive and bank fundingNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Nouscom €120M Series DAptadir Therapeutics €40M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Nouscom €120M Series DAptadir Therapeutics €40M SeedNew companies 2 · Follow-on 0
Stages: Series C+ 2
Microbiotica £36M Series C first closeOMass Therapeutics $310M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Microbiotica £36M Series C first closeAnaCardio €62.5M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Estuary Biotherapeutics $93M Series AOMass Therapeutics $310M Series CNew companies 2 · Follow-on 0
Stages: Series A 2
Estuary Biotherapeutics $93M Series Aai3Bio $48M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.